Latest Video Updates

Upcoming Oncology Education Events

OncologyEducation Events Video Archives

Oncology Clinical News

(AbbVie) May 24, 2018 - AbbVie, a research-based global biopharmaceutical company, today announced that the Phase 3 iLLUMINATE (PCYC-1130) trial met its primary endpoint of improvement in progression-free survival (PFS).
Read full article.

Lung Cancer Rates In Younger White And Hispanic Women Surpass Those Of Men


Read full article.

Powered by OBR Oncology